A clinical evaluation of the antiarthritic agents.
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D000962:Antimalarials / Q000627:therapeutic use; D001168:Arthritis / Q000188:drug therapy*; D001241:Aspirin / Q000627:therapeutic use; D004061:Diflunisal / Q000627:therapeutic use; D005279:Fenoprofen / Q000627:therapeutic use; D005938:Glucocorticoids / Q000627:therapeutic use; D006046:Gold / Q000627:therapeutic use; D006801:Humans; D007052:Ibuprofen / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007213:Indomethacin / Q000627:therapeutic use; D009288:Naproxen / Q000627:therapeutic use; D010396:Penicillamine / Q000627:therapeutic use; D010894:Piroxicam; D011448:Prostaglandin Antagonists / Q000627:therapeutic use; D012459:Salicylates / Q000627:therapeutic use; D013467:Sulindac / Q000627:therapeutic use; D013843:Thiazines / Q000627:therapeutic use; D014046:Tolmetin / Q000627:therapeutic use; D062367:ortho-Aminobenzoates / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000962:Antimalarials; D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D011448:Prostaglandin Antagonists; D012459:Salicylates; D013843:Thiazines; D062367:ortho-Aminobenzoates; D010894:Piroxicam; D013467:Sulindac; D009288:Naproxen; D006046:Gold; D004061:Diflunisal; D014046:Tolmetin; D010396:Penicillamine; D001241:Aspirin; D005279:Fenoprofen; D007052:Ibuprofen; D007213:Indomethacin